Corient Private Wealth
TMDX icon

Corient Private Wealth’s Transmedics TMDX Stock Holding History

Corient Private Wealth’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$858K Buy
8,641
+2,473
+40% +$323K ﹤0.01% 1739
2025
Q4 		$750K Buy
6,168
+3,841
+165% +$482K ﹤0.01% 2056
2025
Q3 		$261K Buy
2,327
+36
+2% +$4.21K ﹤0.01% 2204
2025
Q2 		$307K Buy
+2,291
New +$252K ﹤0.01% 1977
2024
Q4 		– Sell
-1,463
Closed -$230K – 2537
2024
Q3 		$230K Sell
1,463
-500
-25% -$77K ﹤0.01% 2158
2024
Q2 		$296K Buy
+1,963
New +$235K ﹤0.01% 1930

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corient Private Wealth's TMDX Position: Q1 2026 in Review

Corient Private Wealth increased its Transmedics (TMDX) stake by 40% in Q1 2026, buying an estimated $323K and bringing the position to 8,641 shares worth $858K. The position accounts for ﹤0.01% of the portfolio, ranked #1739.

Corient Private Wealth first reported a position in TMDX in Q2 2024 and has held it in 6 quarters since. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Corient Private Wealth held 8,641 shares of Transmedics worth $858K as of Q1 2026.
  • Corient Private Wealth bought 2,473 Transmedics shares in Q1 2026, an estimated $323K.
  • Transmedics made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1739 holding.
  • Corient Private Wealth first reported a position in Transmedics in Q2 2024 and has held it in 6 quarters since.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.